Jerrell Felim

Jerrell Felim

Auto-generated profile, based on publicly available information

Jerrell Felim

Department of Food Science, National Taiwan Ocean University, Keelung, Taiwan

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2025 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
HCHuey-Jine Chai
Huey-Jine Chai
TYTSUNGKAI YI
TSUNGKAI YI
JFJerrell Felim
Jerrell Felim
MTMing-Chieh Tu
Ming-Chieh Tu
ZKZwe-Ling Kong
Zwe-Ling Kong
Muscle atrophy, whether associated with aging, chronic disease, or glucocorticoid treatment, remains a significant clinical challenge with few effective therapeutic options. This study investigated the protective effects of fucoidan from Undaria pinnatifida and peptides derived from the hybrid grouper (Epinephelus fuscoguttatus × Epinephelus lanceolatus) against dexamethasone (DEX)-induced muscle atrophy in vitro and in vivo. In C2C12 myotubes, DEX suppressed anabolic signaling (mTOR, p-Akt, PI3K, p-S6K1, TRPV4) and upregulated catabolic mediators (FOXO3, MuRF1, Atrogin-1, Cathepsin L, REDD2). Fucoidan mainly suppressed catabolic signaling, peptides enhanced anabolic pathways, and their combination synergistically restored protein turnover. In a DEX-induced mouse model, the combined treatment significantly preserved muscle weight, improved strength and endurance, and protected myofiber morphology, exceeding the effects of either treatment alone or leucine. Compositional profiling confirmed that fucoidan was enriched in fucose and sulfate, whereas grouper peptides were abundant in branched-chain amino acids and bioactive dipeptides, supporting their complementary mechanisms. These findings demonstrate that fucoidan and grouper-derived peptides exert distinct yet synergistic effects on muscle protein homeostasis, highlighting their translational potential as safe, mechanism-based interventions for preventing and treating muscle-wasting conditions such as sarcopenia, cachexia, and glucocorticoid-induced atrophy.

13 June 2025 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
JFJerrell Felim
Jerrell Felim
PWPei-Yu Wang
Pei-Yu Wang
Min-Hsiung PanMin-Hsiung Pan
Min-Hsiung Pan
DEDelvina
Delvina
HKHsiang-Ping Kuo
Hsiang-Ping Kuo
ZKZwe-Ling Kong
Zwe-Ling Kong
Osteoarthritis (OA), marked by articular cartilage degeneration, is significantly influenced by obesity, a major risk factor that promotes inflammation and oxidative stress. Sturgeon peptide (SP) is recognized for promoting collagen synthesis essential for cartilage health, while zinc possesses anti-inflammatory properties hampered by low bioavailability. Sturgeon peptide-chelated zinc (SPZ) was developed to overcome this limitation to enhance zinc delivery. This study investigated the therapeutic potential of SP, SPZ, and zinc gluconate in a rat model of obesity-induced OA (OBOA), established via a high-fat diet. Following induction, rats were administered the test compounds orally for six weeks. Plasma pro-inflammatory cytokines, adipokine levels, and markers of oxidative stress and cartilage health were evaluated. Results indicated that the OBOA model successfully induced increased adipokines, inflammation, oxidative stress, and cartilage degradation. All treatment groups (SP, SPZ, zinc gluconate) showed improved adipokine levels and protection against oxidative stress. SP specifically stimulated type II collagen production, contributing to cartilage recovery. However, SPZ, particularly at 150 mg/kg (SPZ2), demonstrated significantly superior protective effects compared to SP or zinc gluconate alone. This enhanced efficacy is attributed to the improved bioavailability of chelated zinc. In conclusion, SPZ2 exhibits substantial protective and recovery properties in OA cartilage, positioning it as a highly promising therapeutic candidate for managing osteoarthritis, potentially offering a novel approach for future treatments.